Personalized Medicine & Targeted Therapies

Personalized medicine and targeted therapies are reshaping cancer care by tailoring treatment strategies to the molecular and genetic characteristics of individual tumors. This approach uses biomarkers, genomic profiling, and molecular diagnostics to identify actionable targets and select therapies most likely to be effective. Targeted treatments, such as kinase inhibitors, hormone therapies, and monoclonal antibodies, disrupt specific pathways essential to cancer growth. Personalized medicine minimizes unnecessary side effects and increases therapeutic success rates by aligning treatment with patient-specific biology. It also supports adaptive treatment plans based on real-time monitoring through liquid biopsies and imaging.

    Related Conference of Personalized Medicine & Targeted Therapies

    December 08-09, 2025

    13th Euro Breast Cancer and Therapeutics

    Paris, France
    February 05-06, 2026

    11th World Conference on Breast and Cervical Cancer

    Paris, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 09-10, 2026

    4th World Congress on Oral Cancer

    Singapore City, Singapore
    June 15-16, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    September 29-30, 2026

    5th Experts Meeting on Cancer Medicine, Radiology & Treatment

    Aix-en-Provence, France

    Personalized Medicine & Targeted Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in